Leishmaniasis e Infecciones Emergentes
University of Texas MD Anderson Cancer Center
Houston, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Texas MD Anderson Cancer Center (1)
2011
-
Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance
Clinical Cancer Research, Vol. 17, Núm. 12, pp. 4155-4166